Activation of epidermal growth factor receptor (EGFR)/Akt pathway mediates G6PD expression. »
11/13/21

Median OS for patients with MAPK-mutated tumors significantly better. »
09/15/21

Median OS prolonged in lenvatinib responders versus nonresponders. »
01/10/22

Co-delivery system designed to inhibit curcumin efflux. »
02/22/22

Patients with annual household income greater than $75,000 and those with some college or higher education significantly more likely to receive SRS. »
03/26/22

Expression of S100P and MACC1 correlated positively in CRC cells and colorectal tumours. »
10/31/21

Weak inverse association between tea consumption and gastric cancer. »
11/17/21

Median OS for patients with MBC found to be 29.8 months. »
10/18/21

DPD suppression rendered cells sensitive to gemcitabine. »
02/03/22

Identified new pro-tumorigenic mechanisms. »
05/26/22